Valve replacement in women of childbearing age: Influences on mother, fetus and neonate

Journal of Heart Valve Disease

Volumn 14, Issue 2, 2005, Pages 151-157

  Mihaljevic, Tomislav ^a   Paul, Subroto ^a   Leacche, Marzia ^a   Rawn, James D ^a   Cohn, Lawrence H ^a   Byrne, John G ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; HEPARIN; WARFARIN;

ADULT; AORTA VALVE REPLACEMENT; ARTICLE; BLEEDING; CESAREAN SECTION; CLINICAL FEATURE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; FEMALE; FETUS; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; MAJOR CLINICAL STUDY; MARFAN SYNDROME; MITRAL VALVE REPLACEMENT; MORBIDITY; MORTALITY; NEWBORN; PREGNANCY; PRIORITY JOURNAL; RHEUMATIC HEART DISEASE; SAINT JUDE HEART VALVE PROSTHESIS; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; THERAPEUTIC ABORTION; TREATMENT OUTCOME; VAGINAL DELIVERY; ADOLESCENT; AORTA VALVE; MITRAL VALVE; POSTOPERATIVE COMPLICATION; PREGNANCY OUTCOME; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AORTIC VALVE; FEMALE; HEART VALVE PROSTHESIS; HUMANS; INFANT, NEWBORN; MITRAL VALVE; POSTOPERATIVE COMPLICATIONS; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 24344437327     PISSN: 09668519     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Iturbe-Alessio I, Fonseca MC, Mutchinik O, Santos MA, Zajarias A, Salazar E. Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med 1986;315:1390-1393
2. Salazar E, Izaguirre R, Verdejo J, Mutchinick O. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses. J Am Coll Cardiol 1996;27:1698-1703
3. Meschengieser SS, Fondevila CG, Santarelli MT, Lazzari MA. Anticoagulation in pregnant women with mechanical heart valve prostheses. Heart 1999;82:23-26
4. Salazar E, Espinola N, Roman L, Casanova JM. Effect of pregnancy on the duration of bovine pericardial bioprostheses. Am Heart J 1999;137:714-720
5. Badduke BR, Jamieson WR, Miyagishima RT, et al. Pregnancy and childbearing in a population with biologic valvular prostheses. J Thorac Cardiovasc Surg 1991;102:179-186
6. Sbarouni E, Oakley CM. Outcome of pregnancy in women with valve prostheses. Br Heart J 1994;71:196-201
7. Al-Lawati AA, Venkitraman M, Al-Delaime T, Valliathu J. Pregnancy and mechanical heart valves replacement; dilemma of anticoagulation. Eur J Cardiothorac Surg 2002;22:223-227
8. Born D, Martinez EE, Almeida PA, et al. Pregnancy in patients with prosthetic heart valves: The effects of anticoagulation on mother, fetus, and neonate. Am Heart J 1992;124:413-417
9. Salazar E, Zajarias A, Gutierrez N, Iturbe I. The problem of cardiac valve prostheses, anticoagulants, and pregnancy. Circulation 1984;70:1169-1177
10. North RA, Sadler L, Stewart AW, McCowan LM, Kerr AR, White HD. Long-term survival and valve-related complications in young women with cardiac valve replacements. Circulation 1999;99:2669-2676
11. Sadler L, McCowan L, White H, Stewart A, Bracken M, North R. Pregnancy outcomes and cardiac complications in women with mechanical, bioprosthetic and homograft valves. Br J Gynaecol 2000;107:245-253
12. Reimold SC, Rutherford JD. Clinical practice. Valvular heart disease in pregnancy. N Engl J Med 2003;349:52-59
13. Ben Ismail M, Abid F, Trabelsi S, Taktak M, Fekih M. Cardiac valve prostheses, anticoagulation, and pregnancy. Br Heart J 1986;55:101-105
14. Goddijn M, Leschot NJ. Genetic aspects of miscarriage. Baillieres Best Pract Res Clin Obstet Gynaecol 2000;14:855-865